5/7/2013 6:54:41 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SOUTH SAN FRANCISCO, Calif., May 7, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. RIGL today reported financial results for the first quarter ended March 31, 2013.
For the first quarter of 2013, Rigel reported a net loss of $25.6 million, or $0.29 per share, compared to a net loss of $23.2 million, or $0.32 per share, in the first quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.
comments powered by